EPI (HOLDINGS) (00689): He Wen Ting appointed as independent non-executive director.
Chang Ying Group (Holdings) (00689) announced that, starting from July 17, 2026: 1. Ms. Jiao Jie resigned as an independent non-executive director of the company, and no longer serves as the chairman of the company's Remuneration Committee, as well as a member of the Audit Committee and Nomination Committee respectively; 2. Ms. Ji Wenting has been appointed as an independent non-executive director of the company, and appointed as a member of the company's Remuneration Committee, Audit Committee, and Nomination Committee respectively.
EPI (Holdings) (00689) announced that, effective July 17, 2026: 1. Ms. Jiao Jie has resigned as an independent non-executive director of the company, and no longer serves as the chairperson of the company's Remuneration Committee, Audit Committee, and Nomination Committee respectively; 2. Ms. Ji Wenting has been appointed as an independent non-executive director of the company, and appointed as a member of the company's Remuneration Committee, Audit Committee, and Nomination Committee respectively.
Related Articles
On July 17th, JACOBIO-B(01167) spent HK$488,000 to repurchase 105,000 shares.
Shanghai Pharmaceuticals Holding(02607) plans to invest 300 million yuan to participate in the establishment of Shanghai Biopharmaceutical Phase II Fund.
Jiangsu Fasten (000890.SZ) applied to issue stocks to specific entities and the application has been accepted by the Shenzhen Stock Exchange.
On July 17th, JACOBIO-B(01167) spent HK$488,000 to repurchase 105,000 shares.
Shanghai Pharmaceuticals Holding(02607) plans to invest 300 million yuan to participate in the establishment of Shanghai Biopharmaceutical Phase II Fund.
Jiangsu Fasten (000890.SZ) applied to issue stocks to specific entities and the application has been accepted by the Shenzhen Stock Exchange.
RECOMMEND
